Menu

Report Library

All Reports
Oral Agents in MS Phases II and III

May 29, 2017

Orally delivered drugs in ongoing and planned Phase II and Phase III industry-sponsored trials for RRMS.

Trialscape is a powerful visual analysis tool derived from the comprehensive clinical trials intelligence in Citeline’s Trialtrove. Each Trialscape map displays the current and future competitive landscape of pharmaceutical clinical trials in a specific area of research. The Trialscape solution provides graphical representation of pharmaceutical clinical trial timelines in support of strategic decisions in drug development, clinical operations and marketing.

In addition to the Trialscape maps available for purchase here, Citeline also offers bundled pricing for all maps in a therapeutic area. If your interest is in areas beyond the current inventory, our analysts will work with you to create a custom deliverable. Please contact analytics@citeline.com for more information.
Disease Group Covered: Neurology
Indications Covered: Ischemic Stroke
Premenstrual Dysphoric Disorder (PMDD)
Sleep Apnea
Smoking Cessation

 Additional Resources: